Integra LifeSciences IART Specialty Surgery — Total Costs & Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's specialty surgery — total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Integra LifeSciences's specialty surgery — total costs & expenses?
- Integra LifeSciences (IART) reported specialty surgery — total costs & expenses of $200.01M in Q1 2026.
- What does specialty surgery — total costs & expenses mean?
- This represents the aggregate of all operating costs, including cost of goods sold, R&D, and SG&A, incurred by the Specialty Surgery segment. It provides a comprehensive view of the total expenditure required to sustain the segment's operations and revenue generation.